Skip to main content
Top
Published in: Indian Journal of Pediatrics 6/2015

01-06-2015 | Original Article

Growth Patterns of HIV Infected Indian Children in Response to ART: A Clinic Based Cohort Study

Authors: Ritu S. Parchure, Vinay V. Kulkarni, Trupti S. Darak, Rahul Mhaskar, Branko Miladinovic, Patricia J. Emmanuel

Published in: Indian Journal of Pediatrics | Issue 6/2015

Login to get access

Abstract

Objective

To describe catch-up growth after antiretroviral therapy (ART) initiation among children living with human immunodeficiency virus (CLHIV), attending a private clinic in India.

Methods

This is a retrospective analysis of data of CLHIV attending Prayas clinic, Pune, India. Height and weight z scores (HAZ, WAZ) were calculated using WHO growth charts. Catch-up growth post-ART was assessed using a mixed method model in cases where baseline and at least one subsequent follow-up HAZ/WAZ were available. STATA 12 was used for statistical analysis.

Results

During 1998 to 2011, 466 children were enrolled (201 girls and 265 boys; median age = 7 y). A total of 302 children were ever started on ART; of which 73 and 76 children were included for analysis for catch up growth in WAZ and HAZ respectively. Median WAZ and HAZ increased from −2.14 to −1.34 (p = 0.007) and −2.42 to −1.94 (p = 0.34), respectively, 3 y post ART. Multivariable analysis using mixed model (adjusted for gender, guardianship, baseline age, baseline WAZ/HAZ, baseline and time varying WHO clinical stage) showed gains in WAZ (coef = 0.2, 95 % CI: −0.06 to 0.46) and HAZ (coef = 0.49, 95 % CI: 0.21 to 0.77) with time on ART. Lower baseline WAZ/HAZ and older age were associated with impaired catch-up growth. Children staying in institutions and with baseline advanced clinical stage showed higher gain in WAZ.

Conclusions

The prevalence of stunting and underweight was high at ART initiation. Sustained catch-up growth was seen with ART. The study highlights the benefit of early ART in achieving normal growth in CLHIV.
Literature
1.
go back to reference Newell ML, Borja MC, Peckham C; European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111:e52–60. Newell ML, Borja MC, Peckham C; European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111:e52–60.
2.
go back to reference Lepage P, Msellati P, Hitimana DG, Bazubagira A, van Goethem C, Simonon A, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J. 1996;15:479–85.CrossRefPubMed Lepage P, Msellati P, Hitimana DG, Bazubagira A, van Goethem C, Simonon A, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J. 1996;15:479–85.CrossRefPubMed
3.
go back to reference Ram M, Gupte N, Nayak U, Kinikar AA, Khandave M, Shankar AV, et al; SWEN India and BJMC-JHU Clinical Trials Study Team. Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India. BMC Infect Dis. 2012;12:282. Ram M, Gupte N, Nayak U, Kinikar AA, Khandave M, Shankar AV, et al; SWEN India and BJMC-JHU Clinical Trials Study Team. Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India. BMC Infect Dis. 2012;12:282.
4.
go back to reference Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, et al; Program for HIV Prevention and Treatment Study Team. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010;51:1449–57. Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, et al; Program for HIV Prevention and Treatment Study Team. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010;51:1449–57.
5.
go back to reference Weigel R, Phiri S, Chiputula F, Gumulira J, Brinkhof M, Gsponer T, et al. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi. Trop Med Int Health. 2010;15:934–44.CrossRefPubMedCentralPubMed Weigel R, Phiri S, Chiputula F, Gumulira J, Brinkhof M, Gsponer T, et al. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi. Trop Med Int Health. 2010;15:934–44.CrossRefPubMedCentralPubMed
6.
go back to reference Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002;109:E25.CrossRefPubMed Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002;109:E25.CrossRefPubMed
7.
go back to reference Nachman SA, Lindsey JC, Moye J, Stanley KE, Johnson GM, Krogstad PA, et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2005;24:352–7.CrossRefPubMed Nachman SA, Lindsey JC, Moye J, Stanley KE, Johnson GM, Krogstad PA, et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2005;24:352–7.CrossRefPubMed
8.
go back to reference Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J. 2007;26:334–8.CrossRefPubMed Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J. 2007;26:334–8.CrossRefPubMed
9.
go back to reference Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384–92.CrossRefPubMed Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384–92.CrossRefPubMed
10.
go back to reference Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS. 2008;22:245–51.CrossRefPubMed Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS. 2008;22:245–51.CrossRefPubMed
11.
go back to reference Aurpibul L, Puthanakit T, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor–based antiretroviral therapy. AIDS Patient Care STDS. 2009;23:1067–71.CrossRefPubMed Aurpibul L, Puthanakit T, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor–based antiretroviral therapy. AIDS Patient Care STDS. 2009;23:1067–71.CrossRefPubMed
12.
go back to reference Department of AIDS control (NACO). Annual Report 2012–13. Department of AIDS control (NACO). Annual Report 2012–13.
13.
go back to reference Panditrao M, Darak S, Kulkarni V, Kulkarni S, Parchure R. Socio-demographic factors associated with loss to follow-up of HIV infected women attending a private sector PMTCT program in Maharashtra, India. AIDS Care. 2011;23:593–600.CrossRefPubMed Panditrao M, Darak S, Kulkarni V, Kulkarni S, Parchure R. Socio-demographic factors associated with loss to follow-up of HIV infected women attending a private sector PMTCT program in Maharashtra, India. AIDS Care. 2011;23:593–600.CrossRefPubMed
14.
go back to reference Singh HK, Gupta A, Siberry GK, Gupte N, Sastry J, Kinikar A, et al. The Indian pediatric HIV epidemic: a systematic review. Curr HIV Res. 2008;6:419–32.CrossRefPubMed Singh HK, Gupta A, Siberry GK, Gupte N, Sastry J, Kinikar A, et al. The Indian pediatric HIV epidemic: a systematic review. Curr HIV Res. 2008;6:419–32.CrossRefPubMed
15.
go back to reference Devi NP, Chandrasekaran K, Bhavani PK, Thiruvalluvan C, Swaminathan S. Persistence of stunting after highly active antiretroviral therapy in HIV-infected children in South India. Indian Pediatr. 2011;48:333–4.PubMed Devi NP, Chandrasekaran K, Bhavani PK, Thiruvalluvan C, Swaminathan S. Persistence of stunting after highly active antiretroviral therapy in HIV-infected children in South India. Indian Pediatr. 2011;48:333–4.PubMed
16.
go back to reference Banerjee T, Pensi T, Banerjee D, Grover G. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India. Ann Trop Paediatr. 2010;30:27–37.CrossRefPubMed Banerjee T, Pensi T, Banerjee D, Grover G. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India. Ann Trop Paediatr. 2010;30:27–37.CrossRefPubMed
17.
go back to reference Bandyopadhyay A, Bhattacharyya S. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Ann Trop Paediatr. 2008;28:279–85.CrossRefPubMed Bandyopadhyay A, Bhattacharyya S. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Ann Trop Paediatr. 2008;28:279–85.CrossRefPubMed
18.
go back to reference WHO. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. 2006. WHO. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. 2006.
21.
go back to reference International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3) 2005–06: India. Mumbai: IIPS; 2007. International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3) 2005–06: India. Mumbai: IIPS; 2007.
22.
go back to reference Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888–99.CrossRefPubMed Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888–99.CrossRefPubMed
23.
go back to reference Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, et al; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730–7. Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, et al; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730–7.
24.
go back to reference Sutcliffe CG, van Dijk JH, Munsanje B, Hamangaba F, Sinywimaanzi P, Thuma PE, et al. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis. 2011;11:54.CrossRefPubMedCentralPubMed Sutcliffe CG, van Dijk JH, Munsanje B, Hamangaba F, Sinywimaanzi P, Thuma PE, et al. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis. 2011;11:54.CrossRefPubMedCentralPubMed
25.
go back to reference Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Vibol U, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12:933–41.CrossRefPubMedCentralPubMed Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Vibol U, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12:933–41.CrossRefPubMedCentralPubMed
26.
go back to reference Anonymous. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics. 1994;94:815–9. Anonymous. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics. 1994;94:815–9.
27.
go back to reference Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56:365–71.CrossRefPubMedCentralPubMed Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56:365–71.CrossRefPubMedCentralPubMed
28.
go back to reference Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS. 2011;25:951–6.CrossRefPubMed Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS. 2011;25:951–6.CrossRefPubMed
29.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013.
30.
go back to reference Puthanakit T, Bunupuradah T. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries. Curr Opin HIV AIDS. 2010;5:12–7.CrossRefPubMed Puthanakit T, Bunupuradah T. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries. Curr Opin HIV AIDS. 2010;5:12–7.CrossRefPubMed
Metadata
Title
Growth Patterns of HIV Infected Indian Children in Response to ART: A Clinic Based Cohort Study
Authors
Ritu S. Parchure
Vinay V. Kulkarni
Trupti S. Darak
Rahul Mhaskar
Branko Miladinovic
Patricia J. Emmanuel
Publication date
01-06-2015
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 6/2015
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-014-1659-1

Other articles of this Issue 6/2015

Indian Journal of Pediatrics 6/2015 Go to the issue